Various anthropometric parameters, obesity and diabetes factors, and BC clinical measures, as well as plasma levels of leptin, CD295, and ITLN1, were collected (Table 1), as was information concerning the SNPs under study and DNA damage parameters for both the BC patients and the healthy controls (Table 2). This evidence concerns the gene ITLN1 and breast cancer.